ARCHIVES

NCI Phone Number Listings Completed

This article is from The Cancer Letter archive.

Vol. 05 No. 38 | September 21, 1979

Download PDF Visit The Full Archive

Related Articles

Cancer Research Faces A “Strategic Inflection,” NCI Director Says

April 19, 2002

FDA Grants Orphan Designation To Photofrin for Mesothelioma

December 30, 2011

Cancer Groups Endorse Richard Pazdur for Head of FDA’s New Office of Oncology Drug Products. Five Candidates Are In the Running for the Job, Sources Said.

February 18, 2005

Cancer Panel To Examine Health Of Phase I Trials

May 17, 1996

Abstracts Of Papers From Conference On Adjuvant Therapy

April 22, 1977

GPC Biotech’s Satraplatin Fails To Extend Survival In Hormone-Refractory Prostate Cancer.

November 2, 2007